Topic
Coronavirus Vaccine
Germany hits million cases as Russia links up with India on vaccine
Although the virus spread is slowing thanks to weeks of tough restrictions, Europe remains at the heart of the pandemic, recording more cases than the United States in the past week
AstraZeneca says its vaccine needs ‘additional study’
AstraZeneca and its partner, the University of Oxford, announced on Monday that it was seeking regulatory approval for the vaccine after it showed an average 70-per cent effectiveness
When can actually Bangladesh avail of COVID-19 vaccine?
The experts said Bangladesh is also unlikely to be able to enhance its existing capacity for storing, transporting and distributing mRNA vaccines overnight as it is a very expensive and ...
Russia says Sputnik V virus vaccine 95pc effective
The calculations of its effectiveness were based on preliminary data obtained 42 days after the first dose, Russia’s health ministry, the state-run Gamaleya research centre and the Russian Direct ...
Wear masks as COVID’s second wave looms large: PM Hasina
Prime minister Sheikh Hasina has renewed her warning that the second wave of COVID-19 pandemic in the country is imminent and asked all to wear masks
Pfizer announces vaccine with 95pc efficacy
The announcement came from Pfizer after another US firm involved in the vaccine race, Moderna, said this week that its own candidate was 94.5 per cent effective, while Russia has also announced a ...
'Formulate well-coordinated roadmap to face COVID crisis'
Sheikh Hasina expressed her optimism that the world is going to get effective vaccines against COVID-19 soon. She has called for making the vaccines available at free of costs for all countries
Bangladesh to buy 30 million doses of Oxford vaccine
Bangladesh will purchase 30 million doses of the coronavirus vaccine manufactured by the Oxford University in UK
Moderna prepares global launch of COVID-19 vaccine
American biotechnology company Moderna announced that it was preparing for the global launch of its Covid-19 vaccine candidate
Positive pre-clinical data for CureVac’s COVID-19 vaccine
The Tuebingen-based company, which is backed by the Bill & Melinda Gates Foundation, said the potential vaccine, known as CVnCoV, produced neutralising antibodies and activated T-cells in hamsters ...
Load More
